Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Patients who have schizophrenia, schizoaffective disorder, a psychotic disorder, and are
being treated with a medication called Risperidone Long Acting Injectable medication or
another antipsychotic medication are candidates for the study. The purpose of the study is to
find out from patients' family how they feel the medication has affected their relationship
with them. The study will involve meeting with family members three times over the course of
one year. The first time will be at New Hampshire Hospital (NHH) or at a community mental
health center and the follow up times will be at a convenient place and time for the family
member (s), in the community. We will ask them to answer questions from the Family Burden
Interview and Quality of Life Questionnaire. The family will not be charged for any test that
is completed solely for this study. The family will be provided a travel stipend to meet with
the researchers.